Back to results
US 2021/0187189 A1Published application
Connected Drug Delivery System for Erythropoietin Stimulating Agents
AssigneeFresenius Medical Care Holdings, Inc.
InventorsDavid Yuds, Sameer Peesapati
Life of this patent
Estimating the term…
Abstract
Methods to treat anemia are provided whereby an erythropoietin stimulating agent (ESA) and an iron supplement are administered by a wearable device, based on patient parameters sensed by the wearable device. The method can involve monitoring patient parameters and dosing an ESA and an iron supplement in real-time, via the wearable device.
Claims30
A wearable device, the device comprising:
- a housing configured to be attached to the skin of a patient during use;
- an injector assembly at least partially housed in the housing and configured to inject (1) a first drug into the patient, through the patient's skin, and (2) a second drug into the patient, through the patient's skin;
- a first sensing system configured to sense one or more patient parameters that are indicative of a need to administer the first drug to the patient, the first sensing system comprising one or more sensors and a control signal generator, the control signal generator being configured to generate a control signal in response to the one or more patient parameters that are sensed;
- a control system within the housing and configured to receive a control signal from the first sensing system and, based on a control signal received, activate the injector assembly to inject the first drug into the patient.
1 more element
(canceled)
-14. (canceled)
-18. (canceled)
-25. (canceled)
-32. (canceled)
(canceled)
-38. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.